Replies to post #3 on Poseida Therapeutics Inc (PSTX)

[jondoeuk]

Yes, I am. My position was reduced after the FDA hold on PSMA-101, but I will wait for the updated data at ASH from BCMA-101. This could inform the potentially registrational PhII trial (including a possible outpatient cohort). Also, work on a number of improvements is ongoing (see my second post).